All lobbying filings
INNOVATIVE FEDERAL STRATEGIES, LLC
INNOVATIVE FEDERAL STRATEGIES, LLC filed a Q3 report for CERUS CORPORATION on October 8, 2025, reporting $40,000 in lobbying income.
Lobbying for CERUS CORPORATION
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 8, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
California
Government bodies contacted
4
Lobbying activity
3
H.R.4016/S.2572 Department of Defense Appropriations Bill, 2026, Title VI, all provisions related to blood safety. H.R.5304/S.2587 Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2026 - Title II, all provisions related to blood safety.
H.R.3838/S.2296 National Defense Authorization Act, 2026, Title XIV, all provisions related to blood safety.
Contacted officials regarding the Red Blood Cell Clinical Trial Program and blood safety issues.